- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 36
Triana Biomedicines emerges with $110m
Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.
Apr 11, 2022Daily Deal Round Up: April 8, 2022
Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.
Apr 8, 2022HIF Global pumps in $260m
Porsche, Baker Hughes and majority shareholder AME all invested in the round, which will support the deployment of HIF's hydrogen fuel projects.
Apr 8, 2022Binance.US rakes in $200m
The cryptocurrency exchange’s US spinoff pulled in a nine-figure sum from investors like Circle Ventures at a post-money valuation of $4.7bn.
Apr 8, 2022Fetch Rewards retrieves $240m
SoftBank, TelevisaUnivision and NielsenIQ helped provide the customer loyalty app developer with fresh capital in a round more than doubling its valuation to $2.5bn.
Apr 8, 2022Sky Mavis scores $150m
Binance and Animoca Brands were among the investors helping the blockchain game developer pay back users that recently fell victim to the Ronin security breach.
Apr 8, 2022Metis makes space for $150m
China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.
Apr 8, 2022Xmov executes $130m in funding
SoftBank Vision Fund 2 co-led the virtual avatar infrastructure builder’s $110m series C round, which emerged alongside a $20m series B featuring new and returning investors.
Apr 8, 2022Deal net: April 8, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Apr 8, 2022Daily Deal Round Up: April 7, 2022
Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.
Apr 7, 2022About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


